Clinical trial: NCT03644602
Section: Procedures
Subsections: Procedures:

Subjects' participation will be entirely voluntary. If subject decide to participate, he/she will be required to have a specific dietary regimen for your energy needs (calculated on the basis of BMI) and the content in FODMAPs, made in accordance with the reference food tables, for 12 weeks. Simple questionnaires will be administrated before starting the forementioned dietetic regimen, after a month of the beginning and three months later.
Clinical trial: NCT03644602
Section: Purpose of Research
Subsections: Informed Consent Form For The Patient Aim Of The Study:

The aim of this study is to evaluate the clinical impact of a low-diet in FODMAPs in patients with irritable bowel syndrome (IBS), celiac disease (CD) on gluten-free diet (GFD) and inflammatory bowel diseases (IBD) in remission. In particular: 1. Evaluate the presence and type of symptoms through a questionnaire at the time of enrollment and after three months of low-dose FODMAPs in three different patient groups (IBS, CD and IBD).  
2. Evaluate the quality of life of the three groups of patients through different questionnaires (specific for each group) before and after dietary changes.  
The study, approved by the Ethics Committee of the University "Federico II" in Naples, lasts 6 months and involves the participation of about 120 patients. Before deciding whether to take part in the study, the participants have all the time to inquire and confront themselves with a family member or other trusted physician. In addition, the participants can withdraw from the study at any time without the need to state the reasons and /or justification and any penalties or loss of benefits to which they are still entitled.